Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden

Erik Lundström^{1

2}, Eva Isaksson³, Per Näsman⁴, Per Wester^{5

6}, Björn Mårtensson⁷, Bo Norrving⁸, Håkan Wallén⁹, Jörgen Borg⁵, Martin Dennis¹⁰, Gillian Mead¹⁰, Graeme J Hankey¹¹, Maree L Hackett^{12

13}, Katharina S Sunnerhagen^{14

15

16

17}; EFFECTS Trial Collaboration

Affiliations

¹ Department of Neuroscience, Neurology, Uppsala University, Akademiska, Sjukhuset, SE-751 85, Uppsala, Sweden. erik.lundstrom@neuro.uu.se.
² Department of Clinical Neuroscience, Neurology, Karolinska Institutet, Nobels väg 6, SE-171 76, Stockholm, Sweden. erik.lundstrom@neuro.uu.se.
³ Department of Clinical Neuroscience, Neurology, Karolinska Institutet, Nobels väg 6, SE-171 76, Stockholm, Sweden.
⁴ Centre for Safety Research, KTH Royal Institute of Technology, TR10 B, SE-100 44, Stockholm, Sweden.
⁵ Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, SE-182 88, Stockholm, Sweden.
⁶ Department of Public Health & Clinical Medicine, Umeå University, SE-901 87, Umeå, Sweden.
⁷ Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
⁸ Department of Clinical Sciences, Lund, Neurology, Skåne University Hospital, Lund University, SE-221 85, Lund, Sweden.
⁹ Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, SE-182 88, Stockholm, Sweden.
¹⁰ Royal Infirmary, University of Edinburgh, Edinburgh, EH16 4SB, UK.
¹¹ Medical School, The University of Western Australia, Perth, Australia.
¹² The George Institute for Global Health, Faculty of Medicine, University of New South Wales Sydney, Sydney, Australia.
¹³ The University of Central Lancashire, Preston, UK.
¹⁴ Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹⁵ Riga Stradins University, Riga, Latvia.
¹⁶ Sunnaas Rehabilitation Hospital, Bjørnemy, Norway.
¹⁷ Rehabilitation Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

PMID: 32381037
PMCID: PMC7203841
DOI: 10.1186/s13063-020-04327-w

Published Erratum

Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden

Erik Lundström et al. Trials. 2020.

. 2020 May 7;21(1):388.

doi: 10.1186/s13063-020-04327-w.

Authors

Affiliations

¹ Department of Neuroscience, Neurology, Uppsala University, Akademiska, Sjukhuset, SE-751 85, Uppsala, Sweden. erik.lundstrom@neuro.uu.se.
² Department of Clinical Neuroscience, Neurology, Karolinska Institutet, Nobels väg 6, SE-171 76, Stockholm, Sweden. erik.lundstrom@neuro.uu.se.
³ Department of Clinical Neuroscience, Neurology, Karolinska Institutet, Nobels väg 6, SE-171 76, Stockholm, Sweden.
⁴ Centre for Safety Research, KTH Royal Institute of Technology, TR10 B, SE-100 44, Stockholm, Sweden.
⁵ Department of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, SE-182 88, Stockholm, Sweden.
⁶ Department of Public Health & Clinical Medicine, Umeå University, SE-901 87, Umeå, Sweden.
⁷ Department of Clinical Neuroscience, Karolinska Institutet, SE-171 77, Stockholm, Sweden.
⁸ Department of Clinical Sciences, Lund, Neurology, Skåne University Hospital, Lund University, SE-221 85, Lund, Sweden.
⁹ Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd Hospital, Karolinska Institutet, SE-182 88, Stockholm, Sweden.
¹⁰ Royal Infirmary, University of Edinburgh, Edinburgh, EH16 4SB, UK.
¹¹ Medical School, The University of Western Australia, Perth, Australia.
¹² The George Institute for Global Health, Faculty of Medicine, University of New South Wales Sydney, Sydney, Australia.
¹³ The University of Central Lancashire, Preston, UK.
¹⁴ Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
¹⁵ Riga Stradins University, Riga, Latvia.
¹⁶ Sunnaas Rehabilitation Hospital, Bjørnemy, Norway.
¹⁷ Rehabilitation Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden.

PMID: 32381037
PMCID: PMC7203841
DOI: 10.1186/s13063-020-04327-w

Abstract

Following publication of the original article [1], we were notified that one of the corresponding author's affiliations was omitted.

PubMed Disclaimer

Erratum for

Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden.
Lundström E, Isaksson E, Näsman P, Wester P, Mårtensson B, Norrving B, Wallén H, Borg J, Dennis M, Mead G, Hankey GJ, Hackett ML, Sunnerhagen KS; EFFECTS Trial Collaboration. Lundström E, et al. Trials. 2020 Feb 28;21(1):233. doi: 10.1186/s13063-020-4124-7. Trials. 2020. PMID: 32111264 Free PMC article.

References

1. Lundström E, et al. Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden. Trials. 2020;21:233. doi: 10.1186/s13063-020-4124-7. - DOI - PMC - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden

Affiliations

Correction to: Update on the EFFECTS study of fluoxetine for stroke recovery: a randomised controlled trial in Sweden

Authors

Affiliations

Abstract

Erratum for

References

Publication types

LinkOut - more resources

Full Text Sources